Skip to main content
Equibles
CTRE logo

CTRE · CareTrust REIT, Inc.

Track CTRE — free

Use CTRE with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$39.57 -0.36 (-0.90%)
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$9.31B
Shares
236.29M

CTRE metrics

74 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$39.93
Market cap
$9.31B

Price action

19 metrics
Price change (1W)
+0.1%
Price change (30D)
-3.1%
Price change (3M)
+3.1%
Price change (6M)
-0.2%
Price change (YTD)
+10.4%
Price change (1Y)
+16.0%
Trailing year
Price change (5Y)
+78.7%
52-week high
$43.40
52-week low
$32.90
Change from 52-week high
-8.0%
Change from 52-week low
+21.4%
Annualized volatility
25.2%
Beta
0.0
RSI (14D)
49.4
Price vs SMA 50
-1.9%
Price vs SMA 200
+2.5%
Avg volume (3M)
2.69M
Relative volume
0.8
Average dollar volume
$106.71M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
236.29M

Valuation

12 metrics
P / E (TTM)
24.8
Trailing earnings · reciprocal yield 4.0%
PEG ratio
2.9
EV / revenue
18.3×
reciprocal yield 5.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
16.3×
reciprocal yield 6.1%
P / book
2.1
reciprocal yield 48.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
20.8
reciprocal yield 4.8%
Earnings yield
3.8%

Historical valuation

8 metrics
P / E historical average (3Y)
30.7×
reciprocal yield 3.3%
P / E historical average (5Y)
65.0×
reciprocal yield 1.5%
EV / revenue historical average (3Y)
18.1×
reciprocal yield 5.5%
EV / revenue historical average (5Y)
16.3×
reciprocal yield 6.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
3.6%
Trailing 12 months
Payout ratio
85.9%
Shareholder yield
3.3%
Dividend / share (TTM)
$1.45
Dividend growth YoY
+16.0%
Dividend growth streak
5
Last ex-dividend
2026-06-30

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-07

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
62.2%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$355.40M
Trailing 12 months
Diluted EPS (TTM)
$1.61
FCF margin
—
Effective tax rate
2.4%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
$1.32
Capital expenditures per diluted share (TTM)
$0.03
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+43.5%
Year over year
Net income growth YoY
+29.8%
Revenue (TTM)
$571.43M
Trailing 12 months
EPS growth YoY
+8.6%
Shares change YoY
+21.5%
Year over year · more shares
Revenue CAGR (3Y)
+34.4%
Revenue CAGR (5Y)
+21.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
+13.1%
FCF CAGR (3Y)
+24.3%
FCF CAGR (5Y)
+115.9%

Quality

14 metrics
Return on equity
7.9%
Return on assets
6.0%
Debt / equity
0.3
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$1.16B
Latest balance sheet
Cash & equivalents
$47.59M
Total assets
$5.93B
Total debt
$1.21B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$446.99M
Capital expenditures (TTM)
$2.94M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
515
13F filer change QoQ
+32
Institutional ownership
106.1%

Short interest

3 metrics
Short interest
10.5%
Latest settlement · 11.3 days to cover
Days to cover
11.3d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1590717 CUSIP 14174T107 13F (30d) 402 filings 376 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)